Reassessment of CXCR4 Chemokine Receptor Expression in Human Normal and Neoplastic Tissues Using the Novel Rabbit Monoclonal Antibody UMB-2

Thomas Fischer, Falko Nagel, Stefan Jacobs et al. · 2008

Read Reassessment of CXCR4 Chemokine Receptor Expression in Human Normal and Neoplastic Tissues Using the Novel Rabbit Monoclonal Antibody UMB-2 by Thomas Fischer, Falko Nagel, Stefan Jacobs et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004069.txt.

Description

Thomas Fischer, Falko Nagel, Stefan Jacobs, and co-authors rechecked a cancer receptor measure in 2008. CXCR4 is a chemokine receptor that steers cell migration. It guides cancer cells toward specific sites where they seed metastases. Knowing a tumor's CXCR4 status could predict its course.

Earlier attempts to locate the receptor in tissue proved unreliable. Their PLOS ONE article validates a new rabbit antibody called UMB-2. With it, they reassessed normal and tumor tissues. A trustworthy stain is the first step toward CXCR4-guided therapy choices. The paper came out in PLOS ONE, an open journal for work in science and health.

Catalog record

CREATORThomas Fischer, Falko Nagel, Stefan Jacobs et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004069

Browse the full library · About the Tower of Babel